AstraZeneca Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Strong Buy" and an average price target of $212.17. The average 1-year stock price forecast is 29.90% higher than the current stock price, while the lowest is $184 (+12.66%) and the highest is $240 (+46.94%).

Price Target: $212.17 (+29.90%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$184	$212.17	$215	$240
Change	+12.66%	+29.90%	+31.64%	+46.94%

Analyst Ratings

The average analyst rating for AstraZeneca stock from 11 stock analysts was "Strong Buy". This means that analysts believed this stock was likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	7	7	7	6	7	7
Buy	2	2	2	2	3	3
Hold	1	1	1	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Colin White UBS	UBS	Buy Maintains $203	Buy	Maintains	$203	+24.39%	Sep 16, 2026
Emmanuel Papadakis Deutsche Bank	Deutsche Bank	Hold Upgrades $154 → $156	Hold	Upgrades	$154 → $156	-4.25%	Sep 15, 2026
Luisa Hector Berenberg Bank	Berenberg Bank	Buy Maintains $214 → $200	Buy	Maintains	$214 → $200	+22.76%	Sep 15, 2026
Trung Huynh RBC Capital	RBC Capital	Buy Maintains $194	Buy	Maintains	$194	+18.66%	Sep 15, 2026
Sachin Jain Bank of America Securities	Bank of America Securities	Buy Maintains $221	Buy	Maintains	$221	+35.03%	Sep 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

63.12B

from 58.74B

7.46%

from 58.74B

Revenue Next Year

66.98B

from 63.12B

6.11%

from 63.12B

EPS This Year

10.25

from 9.16

11.95%

from 9.16

EPS Next Year

11.44

from 10.25

11.52%

from 10.25

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	37.42B	44.35B	45.81B	54.07B	58.74B	63.12B
Revenue Growth	40.58%	18.53%	3.29%	18.04%	8.63%	7.46%
Gross Profit	25.41B	35.71B	37.77B	44.44B	47.99B	52.09B
Gross Margin	67.92%	80.52%	82.44%	82.18%	81.71%	82.53%
Operating Income	2.90B	8.81B	9.70B	12.93B	14.29B	21.09B
Net Income	112.00M	3.29B	5.96B	7.04B	10.23B	12.07B
EPS	-	-	-	-	9.16	10.25
EPS Growth	-	-	-	-	11.57%	11.95%
Forward PE	-	-	-	-	-	15.93
Dividend / Share	2.87	2.90	2.90	3.10	3.20	3.33
Dividend Growth	2.50%	1.05%	-	6.90%	3.23%	4.20%
Free Cash Flow	-	-	-	-	11.77B	9.59B
No. Analysts	-	-	-	-	-	27

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	64.4B
Avg	63.1B
Low	59.0B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	9.6%
Avg	7.5%
Low	0.4%

EPS Forecast

Chart

EPS	2026	2027	2028
High	10.58
Avg	10.25
Low	9.64

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	15.5%
Avg	11.9%
Low	5.3%